MEREO BIOPHARMA 1 LIMITED

Patent Applications and Registrations

Patent applications and USPTO patent grants for MEREO BIOPHARMA 1 LIMITED.The latest application filed is for "synthetic method for the preparation of an alkoxymethylene-benzoylacetonitrile".

Company Profile

22.16.24

MEREO BIOPHARMA 1 LIMITED - London GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzami- de Grant 11,434,204 - Suleiman , et al. September 6, 2	2022-09-06
Synthetic Method For The Preparation Of An Alkoxymethylene-benzoylacetonitrile App 20220033352 - MEISENBACH; Mark ; et al.	2022-02-03
Use of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- enzamide in the prevention or reduction of acute exacerbations of chronic obstructive pulmonary disease Grant 11,234,967 - Parkin , et al. February 1, 2	2022-02-01
Synthetic Method For The Preparation Of A 3-[5-amino-4-(3-cyanobenzoyl)- Pyrazol Compound App 20210395207 - MEISENBACH; Mark ; et al.	2021-12-23
Synthetic Method For The Preparation Of An Hydrazine Compound App 20210340108 - LI; Yunzhong ; et al.	2021-11-04
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease Grant 11,129,810 - Orford , et al. September 28, 2	2021-09-28
Method For Producing A Polymorphic Form Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzami- De App 20210206726 - SULEIMAN; Osama ; et al.	2021-07-08
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzami- de Grant 10,995,071 - Suleiman , et al. May 4, 2	2021-05-04
Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide Grant 10,934,260 - Suleiman , et al. March 2, 2	2021-03-02
Use Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- Enzamide In The Prevention Or Reduction Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200383950 - PARKIN; Jacqueline ; et al.	2020-12-10
Use Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylb- Enzamide In The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200352909 - MACKINNON; Alastair ; et al.	2020-11-12
Dosage Regimen For The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20200281896 - ORFORD; Colin ; et al.	2020-09-10
Dosage regimen for the treatment of acute exacerbations of inflammatory conditions Grant 10,617,674 - Orford , et al.	2020-04-14
Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease Grant 10,603,306 - Orford , et al.	2020-03-31
Method For Producing A Polymorphic Form Of 3-[5-amino-4-(3- Cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide App 20190352269 - SULEIMAN; Osama ; et al.	2019-11-21
Method For Producing A Polymorphic Form Of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzami- De App 20190315694 - SULEIMAN; Osama ; et al.	2019-10-17
Dosage Regimen For The Treatment Of Acute Exacerbations Of Inflammatory Conditions App 20190091203 - ORFORD; Colin ; et al.	2019-03-28
Dosage Regimen For The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20190060279 - ORFORD; Colin ; et al.	2019-02-28
Use Of A Pyrazole Derivative In The Treatment Of Acute Exacerbations Of Chronic Obstructive Pulmonary Disease App 20160243081 - FORD; Paul Andrew	2016-08-25
Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease Grant 9,339,491 - Ford May 17, 2	2016-05-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.